Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic Shock: The SEPSIS-ACT Randomized Clinical Trial (vol 322, pg 1476, 2019)

Laterre P-F; Berry S. M.; Blemings A.

首页> 外文期刊>JAMA: the Journal of the American Medical Association >Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic Shock: The SEPSIS-ACT Randomized Clinical Trial (vol 322, pg 1476, 2019)

【24h】

Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic Shock: The SEPSIS-ACT Randomized Clinical Trial (vol 322, pg 1476, 2019)

机译：Selepressin VS安慰剂对脓毒症休克患者呼吸机和血管连接天的影响：Sepsis-Act随机临床试验（Vol 322，PG 1476,2019）

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《JAMA: the Journal of the American Medical Association》 |2019年第18期|共1页
作者
Laterre P-F; Berry S. M.; Blemings A.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医药、卫生;
关键词

相似文献

外文文献
中文文献
专利

1. Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic Shock: The SEPSIS-ACT Randomized Clinical Trial (vol 322, pg 1476, 2019) [J] . Laterre P-F, Berry S. M., Blemings A. JAMA: the Journal of the American Medical Association . 2019,第18期

机译：Selepressin VS安慰剂对脓毒症休克患者呼吸机和血管连接天的影响：Sepsis-Act随机临床试验（Vol 322，PG 1476,2019）
2. Effect of Filgotinib vs Placebo on Clinical Response in Patients With Moderate to Severe Rheumatoid Arthritis Refractory to Disease-Modifying Antirheumatic Drug Therapy:The FINCH2 Randomized Clinical Trial (vol 322, pg 315, 2019) [J] . Genovese M. C., Kalunian K., Gottenberg J-E JAMA: the Journal of the American Medical Association . 2020,第5期

机译：Filgotinib VS安慰剂对中度至重度类风湿性关节炎患者临床反应对疾病修饰抗胃部药物治疗的影响：FINCH2随机临床试验（Vol 322，PG 315,2019）
3. Effect of bempedoic acid vs placebo added to maximally tolerated statins on low-density lipoprotein cholesterol in patients at high risk for cardiovascular disease: the CLEAR Wisdom randomized clinical trial (vol 322, pg 1780, 2019) [J] . Goldberg A. C., Leiter L. A., Stroes E. S. G. JAMA: the Journal of the American Medical Association . 2020,第3期

机译：Bempedo酸与安慰剂的影响在心血管疾病高风险患者中添加到最大耐受的他汀类药物中的最大耐脂蛋白胆固醇：清晰的智慧随机临床试验（Vol 322，PG 1780,2019）
4. EFFECT OF TARGETED PULSED ELECTROMAGNETIC FIELD THERAPY ON CANINE POST-OPERATIVE HEMILAMINECTOMY: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL [C] . ACVS Veterinary Symposium . 2018

机译：靶向脉冲电磁场治疗对犬术后血栓切除术的影响：双盲，随机，安慰剂对照临床试验
5. A Randomized, Double-blind, Placebo-controlled Clinical Trial Evaluating the Effect of Infliximab on General Cognition in a Population of Depressed Individuals with Bipolar Disorder Type I/II [D] . Pan, Zihang. 2018

机译：一项随机，双盲，安慰剂对照的临床试验，评估英夫利昔单抗对I / II型双相情感障碍抑郁症患者总体认知的影响
6. Selepressin a novel selective vasopressin V1A agonist is an effective substitute for norepinephrine in a phase IIa randomized placebo-controlled trial in septic shock patients [O] . James A. Russell, Jean-Louis Vincent, Anne Louise Kjølbye, 2017

机译：Selepressin是一种新型的选择性加压素V1A激动剂在败血性休克患者的IIa期随机安慰剂对照试验中可有效替代去甲肾上腺素
7. Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients [O] . Russell, James, Vincent, Jean Louis, Kjølbye, Anne Louise, 2017

机译：Selepressin是一种新型的选择性加压素V1A激动剂，在败血性休克患者的IIa期随机，安慰剂对照试验中可有效替代去甲肾上腺素

Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic Shock: The SEPSIS-ACT Randomized Clinical Trial (vol 322, pg 1476, 2019)

著录项

相似文献

相关主题

期刊订阅